MARKSANS PHARMA
Back to Balance Sheet
|
MARKSANS PHARMA Last 5 Year Total Non-Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Non-Current Liabilities | ₹273 Cr | ₹205 Cr | ₹84 Cr | ₹57 Cr | ₹24 Cr |
What is the latest Total Non-Current Liabilities ratio of MARKSANS PHARMA ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2025 | ₹273 Cr |
| Mar2024 | ₹205 Cr |
| Mar2023 | ₹84 Cr |
| Mar2022 | ₹57 Cr |
| Mar2021 | ₹24 Cr |
How is Total Non-Current Liabilities of MARKSANS PHARMA Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹273 Cr | 33.00 | |
| Mar2024 | ₹205 Cr | 143.34 | |
| Mar2023 | ₹84 Cr | 47.80 | |
| Mar2022 | ₹57 Cr | 140.72 | |
| Mar2021 | ₹24 Cr | - | |
Compare Total Non-Current Liabilities of peers of MARKSANS PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| MARKSANS PHARMA | ₹7,448.3 Cr | 1.1% | -8.6% | -26.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹390,828.0 Cr | 1.2% | -5.3% | -5.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹158,227.0 Cr | -3.9% | -6% | 11.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹135,045.0 Cr | 0.9% | 3.7% | 20.5% | Stock Analytics | |
| CIPLA | ₹105,961.0 Cr | -1.2% | -12.6% | -6.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹98,682.5 Cr | -3.4% | -5.7% | 0.3% | Stock Analytics | |
MARKSANS PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| MARKSANS PHARMA | 1.1% |
-8.6% |
-26.4% |
| SENSEX | -0.2% |
-4.2% |
8.4% |
You may also like the below Video Courses